The adult epilepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan)…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In his latest weekly clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, delved into a multifaceted array of critical public…
Read More
TWiV 1292: Clinical Update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) have voiced significant…
Read More
The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties
The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…
Read More
TWiV 1284: Clinical update with Dr. Daniel Griffin
In a recent broadcast of "This Week in Virology" (TWiV), episode 1284, Dr. Daniel Griffin and Vincent Racaniello provided a…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin
The latest installment of "This Week in Virology" (TWiV) podcast, episode 1286, featured a comprehensive clinical update from Dr. Daniel…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Resurging Public Health Threats
In a recent clinical update on the influential "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, alongside host Vincent…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In a comprehensive clinical update delivered on This Week in Virology (TWiV) episode 1290, Dr. Daniel Griffin provided an in-depth…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
In a stark assessment of the current state of American public health, Dr. Daniel Griffin, a prominent infectious disease clinician,…
Read MoreYOU MAY HAVE MISSED
